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The amygdala: Site of genomic and nongenomic arousal of effects on the brain has not yet been completely eluci-
aldosterone-induced sodium intake. dated, their actions include both rapid nongenomic
Background. Mineralocorticoids act on the brain to influ- mechanisms that may involve GABA receptors [4–9]ence sodium intake, and they do so via intracellular type I
and slower genomic induction incorporating cytosolicreceptors and possibly also via a direct membrane action, as
mineralocorticoid receptors (MRs) [10, 11] that involvethey do in the kidney. One brain area implicated by lesion
studies investigating the regulation of sodium appetite aroused a synergy of MR with other neuropeptides, especially
by adrenal steroids is the amygdala. angiotensin II [11–14], as well as suppression of other
Methods. To examine the mechanism by which mineralocor- neuropeptides, most notably oxytocin [15–17], that nor-ticoids act in the amygdala to arouse salt intake via a genomic
mally inhibit sodium ingestion.and or membrane mode of action, rats were bilaterally fitted
with cannulae directed to terminate in the amygdala. The geno- Here, we review a series of studies that support the
mic action of mineralocorticoids in arousing sodium intake was findings that mineralocorticoids act on the brain to in-
investigated by the administration of antisense oligodeoxy- fluence sodium intake, and that they do so via intracellu-
nucleotides (ASDNs) against the mineralocorticoid receptor,
lar type I receptors and also via direct membrane action,and its effects on deoxycorticosterone (DOCA)-induced so-
as they do in kidney and vascular tissue. Although thedium intake over the course of several days was examined.
The nongenomic action of mineralocorticoids on sodium intake mineralocorticoids acting through classic genomic mech-
was investigated by implantation into the amygdala of DOCA, anisms to arouse sodium intake have been well docu-
aldosterone (ALDO), or their A-ring–reduced tetrahydro de- mented, their novel nongenomic mode of action throughrivatives, 15 minutes prior to access to saline. Sodium intake
membrane receptors that may engage the GABA/benzo-was monitored immediately thereafter.
diazepine receptor or a unique receptor system of theirResults. Treatment of rats in the amygdala with ASDN against
the mineralocorticoid receptor inhibited DOCA-induced so- own in producing a rapid increase in sodium intake is
dium intake, whereas ASDN against the glucocorticoid recep- quite intriguing. Furthermore, it seems that the brain
tor or sense/scrambled sequences had no effect. DOCA and
nuclei in the amygdala possess the receptors that allowALDO increased saline intake within 15 minutes after steroid
the mineralocorticoids to act through both genomic andapplication. Similarly, the application of A-ring–reduced 3b,5b
tetrahydroaldosterone and 5 a-tetrahydrodeoxycorticosterone nongenomic mechanisms to arouse sodium intake.
produced the same increases in sodium intake. Previous studies have used receptor antagonists to ex-
Conclusions. Together, the data imply that adrenal steroids, amine the contribution of MRs and glucocorticoid recep-in addition to acting through classic cytosolic receptors, may
tor (GRs) in sodium appetite [11]. Their use has metalso act on membrane receptor systems, producing rapid
with some success by partially inhibiting sodium appetitechanges in behavior.
aroused by either the exogenous administration of aldo-
sterone (ALDO) or deoxycorticosterone (DOCA) or by
The arousal of salt appetite by mineralocorticoids is sodium depletion treatments, which elevate the endoge-
an innate and highly specific behavior [1, 2]. Rats treated nous levels of mineralocorticoids [11, 13]. However, their
exogenously with mineralocorticoids exhibit a robust in- use has been limited because of their lack of specificity
gestion of sodium-rich ingesta and will even perform for receptor subtypes, the short half-life of most antago-
operant tasks to obtain saline rewards [3]. Although the nists, and the lack of regional localization or sites of
mechanism through which mineralocorticoids evoke their action when injected into the brain ventricular system
[18]. As an alternative method to investigate adrenal
steroid receptor involvement in sodium appetite, weKey words: sodium appetite, amygdala, adrenal steroids, A-ring re-
duced steroids, ALDO, DOCA, flunitrazepam. have used antisense oligodeoxynucleotides (ASDNs)
that interfere with endogenous receptor activity. By theirÓ 2000 by the International Society of Nephrology
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design, the ASDN sequences were designed to interfere was initiated. Before inclusion in experiments, cannula
placement and patency were validated by a pulse ICVwith the type I MRs, thus interfering with the genomic
injection of 6 ng of angiotensin II to which a criterionactions of ALDO.
response of at least 5 mL of water intake in 15 minutesThe subnuclei of the amygdala has been identified as
was required for participation in subsequent experiments.containing large concentrations of MRs and that electri-
A second group of male rats was surgically fitted withcal or chemical lesions of this brain area render the
bilateral guide cannula stereotaxically directed to termi-animal insensitive to mineralocorticoid-induced sodium
nate above the medial area of the amygdala. Surgery wasintake [19, 20]. Similarly, we have found that local contin-
performed under ketamine/acepromazine anesthesia (40uous infusions of MR antagonists into this are also effec-
mg Ket, 20 mg Ace/100 g body wt). The guide cannulastive in suppressing mineralocorticoid-induced sodium in-
were permanently fixed to the skull with stainless steeltake [21]. As a further extension of the studies examining
bone screws and dental acrylic. Once fitted with guidethe genomic actions of mineralocorticoids on sodium in-
cannula, the animals were allowed at least one week oftake, the first series of experiments investigates whether
recovery before the experiments were begun.ASDNs, which target the MRs, could reverse an estab-
lished DOCA-induced salt appetite. Based on the find- Oligodeoxynucleotide probes
ings of the identification of a brain-sensitive site (the
Antisense oligodeoxynucleotide sequences were de-amygdala) to mineralocorticoids, the effects of direct
signed on sequences of the cloned rat MR [22] and GR.administration of various adrenal steroids on salt intake
The MR antisense oligonucleotide sequence, 15 mer,and their mechanism of action are further examined in
which was used in the experiments, corresponds to nucle-the second series of studies. Together, the two series of
otides 2 to 16 of the 59 end of the translated region ofstudies examine whether mineralocorticoids can act in
the MR mRNA and was 59 CAT-GTC-TAG-GCC-TTCthe amygdala through genomic and nongenomic mecha-
39. The GR antisense oligonucleotide sequence, 18 mer,nisms to arouse sodium appetite in the rat.
was also 59 directed to the ATG initiation site of the
GR mRNA and was 59 GGA-TTC-TTT-GGA-GTC-
METHODS CAT 39. In addition, the control sequences used were
MR sense, 59 GAA-GGC-CTA-GAC-ATG 39; GR sense,Animals
59 ATG-GAC-TCC-AAA-GAA-TCC 39; MR scram-Adult, male Harlan Sprague-Dawley rats (N 5 6 per
bled, 59 CAT-TTT-GAA-GGT-TCC 39; and GR scram-experimental group) weighing 300 to 350 g at the initia-
bled, 59 GGA-TTT-GAA-GGT-TCC 39. All nucleotide
tion of the experiment were individually housed in metal sequences were synthesized by Oligo’s Etc. Inc. (Wilson-
cages in a temperature controlled room (22 6 28C) and ville, OR, USA) and contained phosphorothioate modi-
maintained on a 12-hour light/dark cycle. The animals fications to reduced susceptibility to nuclease degrada-
were given ad libitum access to Purina rodent chow, tap tion in vivo. One microliter pulse ICV (pICV) injections
water, and 0.5 mol/L NaCl, unless otherwise noted. Daily of oligonucleotides were given on three consecutive days
fluid intakes were recorded to the nearest milliliter. to conscious animals using an injector (Plastics 1), which
terminated 1 mm past the end of the guide cannula.Surgery
Control animals received equivalent amounts of either
Rats receiving intracerebroventricular (ICV) injec- scrambled/sense oligodeoxynucleotides or isotonic saline
tions were anesthetized under Ketamine HCl (intramus- vehicle. The ASDN sequences for MR and GR at the
cularly 100 mg/kg body wt; Bristol Laboratories, Syra- doses used have been previously shown to decrease the
cuse, NY, USA) and Acepromazine (intramuscularly targeted receptors by 40 to 60% [23].
1.37 mg/kg body weight; Ayerst Laboratories, Inc., New
York, NY, USA) anesthesia and were injected with a Steroids
prophylactic dose of Gentamicin (10 mg intramuscularly; Aldosterone, DOCA, corticosterone (CORT), 3b,5b
Schering-Plough Animals Health Corp., Kenilworth, NJ, tetrahydroaldosterone (TH-ALDO), 3b,5b tetrahydro-
USA) prior to surgery. Rats were fitted with an ICV corticosterone (TH-CORT), and 5 a-tetrahydrodeoxy-
guide cannula (Plastics 1, Roanoke, VA, USA) that was corticosterone (TH-DOC) were acquired from Sigma
stereotaxically implanted to terminate in the third ventri- Chemical Company (St. Louis, MO, USA). Allopregna-
cle and fixed to the skull with dental acrylic and three nolone (3 a OH DHP) was a gift from CoCensys Inc..
stainless-steel screws. The following stereotaxic coordi- Ru28362 was received as a gift from Roussel-UCLAF
nates were used: 1.0 mm posterior to bregma, 1.0 mm (Romanville, France).
lateral to the sinus and angled toward the midline at 108,
Adrenal steroid receptor antagonistsand 7.5 mm ventral from the dura. One week of recovery
was allowed for daily food and fluid intake, as well as The role of the cytosolic mineralocorticoid and GR
in the elicitation of the rapid increase in salt appetite bybody weight, to return to presurgery levels before testing
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application of local steroids was examined by interfering
with their function using either the type I MR antagonist
RU 28318 or the type II GR antagonist RU 486 (Roussel-
UCLAF). RU 28318 or RU 486 was applied for one hour
through the same guide cannula as the steroid implant
cannula and was then removed just prior to application
of the steroids of interest. Salt intake was measured as
described in each experiment.
GABA/benzodiazepine receptor manipulations
In a separate set of rats maintained on normal food,
the effects of local application of the GABA agonist
flunitrazepam (Sigma) on salt appetite were examined.
Because of the high binding affinity of the A-ring–reduced
TH steroids to the GABAa/benzodiazepine receptor, we
examined whether the effects of the TH steroids could
be mimicked by this GABA agonist. To further elucidate
the role of the endogenous GABA/benzodiazepine re-
ceptor complex, the GABA receptor antagonist Ro15-
Fig. 1. Daily 0.5 mol/L NaCl intake of animals treated with subcutane-4513 or Ro15-1788 was applied 15 minutes prior to fluni-
ously administered deoxycorticosterone (DOCA; 2.5 mg/day, N 5 8trazepam or TH-DOC application. The ingestion of 0.25 per group). Sodium intake aroused by DOCA treatment is suppressed
mol/L NaCl was measured as described. by pulse intracerebroventricular (pICV) mineralocorticoid receptor
(MR) antisense oligonucleotides (500 ng/day); the appetite returns to
levels similar to that of vehicle-treated animals when the treatmentsExperiment 1
are switched to pICV glucocorticoid receptor (GR) antisense oligonu-
Experiment 1 shows the effect of pulse ICV adminis- cleotides. The sodium intake of all animals returned to basal levels
when all treatments were terminated.tration of MR ASDN on DOCA-induced salt appetite
in the rat.
The first series of experiments investigated whether
ASDN could reverse an established DOCA-induced salt Experiment 2
appetite. In the first phase of this study, salt appetite was Experiment 2 shows the effect of the administration
aroused in surgically prepared rats (N 5 6 per group) by of MR ASDN into the medial amygdala on DOCA-
daily injections of DOCA (2.5 mg/day, subcutaneously) induced salt appetite in the rat.
for three days. At the end of the third day, half of the In addition to experiments involving intraventricular
animals received daily MR antisense oligonucleotides application of MR ASDN, we also employed direct intra-
(pICV 1.0 mg/day) or isotonic saline into the third ventri- cerebral injection of the oligodeoxynucleotides. A role
cle along with continued subcutaneous DOCA treatment for the amygdala in the control of salt appetite has been
for three days. Following the three days of pICV MR suggested by previous studies demonstrating that rats
antisense oligonucleotide or isotonic saline treatments, with ablations of their amygdala are insensitive to the
the MR antisense oligonucleotide injections were replaced natriorexigenic effects of DOCA [20, 24, 25]. In this
with daily pICV GR antisense oligonucleotide (1.0 mg/ second set of experiments, we extended this investigation
day) for three additional days with daily subcutaneous by using bilateral injections of MR and GR ASDN (500
DOCA injection after which all injections were termi- ng per side) into the amygdala. Although daily spontane-
nated but daily intake of 0.5 mol/L NaCl was recorded. ous intakes of water and saline were not effected by the
Daily subcutaneous injections of 2.5 mg of DOCA oligodeoxynucleotides alone, the expression of elevated
produced a sodium appetite in all rats examined. The salt intake induced by concurrent administration of
addition of daily pulse ICV injections of MR antisense DOCA (2.5 mg/day) was prevented in animals treated
oligonucleotides into the anterior third ventricle sup- with MR ASDN (Fig. 2). The suppression by MR
pressed and reversed subcutaneous injection of DOCA- ASDNs was specific to saline intake, as the animal’s
induced salt appetite as compared with pICV saline- daily water intake was not effected (data not shown).
treated animals (Fig. 1). This suppression of DOCA- Treatment of animals with GR ASDN or sense/scram-
induced salt appetite was reversed by daily pICV injec- bled sequences was ineffective in suppressing DOCA-
tions of GR antisense oligonucleotides. Once all treat- induced sodium intake. Figure 3 shows the distribution
ments were withdrawn, daily intake of 0.5 mol/L NaCl of the antisense treatments in the amygdala based on
of both animals treated with pICV oligonucleotides or biotin-labeled ASDN identified post hoc by immunocy-
tochemistry.pICV saline returned to pretest levels.
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Fig. 2. Effect of daily bilateral intraparen-
chymal injections of mineralocorticoid recep-
tor (MR) or glucocorticoid receptor (GR)
antisense oligonucleotides into the amygdala
in established deoxycorticosterone (DOCA)-
induced sodium appetite rats. The suppression
of sodium intake was produced by MR anti-
sense oligonucleotides treatment, but was re-
versed when scrambled/random oligonucleo-
tides were administered. The treatment of a
separate group of animals with GR antisense
oligonucleotides was ineffective in suppress-
ing DOCA-induced sodium intake. Symbols
are: (s) pICV vehicle; (d) pICV MR or GR
antisense. *P , 0.05 vs. saline 1 DOCA.
Experiment 3 A-ring–reduced steroids (TH-ALDO, TH-CORT, TH-
DOC, 3 a OH DHP) or control implants in a counterbal-Can ALDO, CORT, DOCA, and their A-ring–reduced
anced fashion, but their salt intakes were measured onlymetabolites administered in the amygdala induce sodium
for the two hours immediately after steroid implants andintake in the rat?
not on the following day.Early studies using electrolytic or chemical lesions of
In experiment 3, in contrast to experiments 1 and 2,the various subnuclei of the amygdala produced an atten-
uated response of salt drinking when rats were treated the intake of 0.25 mol/L NaCl of rats was evaluated
with mineralocorticoids [19, 20, 25]. This suggested that immediately after the various bilateral steroid implants
a population of cells within the amygdala, as further were administered. The most marked increases in saline
confirmed by our MR ASDN studies, are mineralocorti- consumption was seen with implants of TH-ALDO and
coid sensitive and important in the arousal of this model TH-DOC. ALDO also activated significant salt intake
of salt intake. In this study, we examined the effects of within 15 to 30 minutes, but DOC produced only a weak
direct stimulation of this brain site with various adrenal activation (Fig. 4). Other tetrahydro derivatives of CORT
steroids or their A-ring–reduced, tetrahydro derivatives, and progesterone were much less effective compared
that is, TH-CORT, TH-ALDO, and TH-DOC, on the with TH-ALDO and TH-DOC. Implants of glucocorti-
expression of salt appetite. These latter compounds are coids such as CORT and the synthetic glucocorticoid
of special interest since in addition to their endogenous RU 28362 were ineffective in arousing sodium intake
production in brain, they are known to activate GABAa (data not shown). Furthermore, as shown in Figure 4,
receptors.
the increase in sodium intake occurred rapidly after the
Rats (N 5 6 to 8 per experiment) were stereotaxically
steroids were implanted, within 15 minutes and continu-fitted with bilateral cannula, as described previously in
ing to 30 minutes, but there was no further effect whenthis article, maintained on normal food and water, and
0.25 mol/L NaCl was made available 24 hours later aftergiven daily access to 0.25 mol/L NaCl to drink each day.
overnight implant of steroids (data not shown, all intakesOnce a stable baseline intake of saline was achieved
less than 0.5 mL over 30 min).(usually 3 to 4 days), the effects of the various steroid
The application of steroids or their TH derivativesimplants were examined. All rats received ALDO,
was only effective when introduced into the medial areaCORT, DOCA, the synthetic glucocorticoid RU 28362,
of the amygdala and overlapped with the area describedor control implants in a counterbalanced fashion, while
in Figure 3. Steroid implants in the bed nucleus of thetheir salt intakes were measured both immediately after
stria terminalis, the paraventricular nucleus of the hypo-steroid implantation for two hours or the following day
thalamus, or areas more lateral to the medial region ofafter overnight steroid application, again for two hours.
A second group of eight rats were treated with the the amygdala were completely ineffective in stimulating
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Fig. 3. Coronal section of rat brain, taken from the Paxinos and Watson Rat Brain Atlas, which shows the location of the cannula terminating
in the amygdala. Only rats in which their implants terminated in this brain area were used in the analysis.
saline intake either immediately after steroid application the amygdala, may be dependent on prior priming
or over the subsequent 24-hour period (data not shown). through a background of the genomic actions of the
adrenal steroids. That is, the TH-ALDO/ALDO-induced
Experiment 4 saline intake may be operating in the context of adrenal
steroid action, which is of genomic nature and whichCan the rapid effects of adrenal steroid-induced salt
intake be blocked by agents that antagonize the classic prepares the brain to respond to the rapid salt appetite-
eliciting effects of these steroids. To interfere with theseadrenal steroid receptor?
The rapid effects of ALDO and DOC, which induce genomic actions of the mineralocorticoids, rats (N 5 6)
were pretreated with the MR antagonist RU 28318 (200salt intake within 15 minutes after steroid application in
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Fig. 4. Bilateral implants of steroid and their tetrahydro derivatives
(TH-ALDO or TH-DOC) directly into the amygdala produced a rapid
increases in 0.25 mol/L NaCl intake as compared with blank or choles-
terol implants (*P , 0.05). Symbols are: (h) blank; (r) cholesterol;
( ) ALDO; (s) TH-ALDO; (j) DOCA; (n) TH-DOCA. Results
are presented as mean 6 SEM.
pg/implant) for one hour prior to the application of
ALDO or TH-ALDO, or they received ALDO or TH-
ALDO alone in a counterbalanced order, as described
in experiment 3, and their intake of 0.25 mol/L NaCl
was recorded. Figure 5 shows that the effect of TH-
ALDO in stimulating 0.25 mol/L NaCl intake was not
significantly suppressed by a one-hour pretreatment with
either the type I MR antagonist RU 28318 or by the
type II GR antagonist RU 486. However, the effects of
ALDO were blocked by pretreatment with RU 28318.
Salt intake after TH-DOC was similar to that for TH-
ALDO (Fig. 5), and the activation of 0.25 mol/L NaCl Fig. 5. An intake of 0.25 mol/L NaCl was increased by bilateral im-
plants of (A) ALDO or TH-ALDO, and (B) DOC or TH-DOC. (A)intake by TH-DOC was not blocked by RU 28318 or by
ALDO or (B) DOC-induced 0.25 mol/L NaCl intake is inhibited bythe type II GR antagonist RU 486. As in experiment 3, one-hour pretreatment with mineralocorticoid receptor antagonist RU
DOC itself had only a weak effect to activate salt intake, 28318 (*P , 0.05 in A and B), but not by glucocorticoid receptor
antagonist RU 486 (B). RU 28318 or RU 486 is not effective on 0.25and this effect was weakly antagonized by RU 28318
mol/L NaCl intake induced by TH-ALDO or TH-DOC (seen in A andand not by RU 486. B). Symbols in A are: (s) blank; (h) ALDO; (j) TH-ALDO; (d)
ALDO 1 RU 28318; (m) TH-ALDO 1 RU 28318. Symbols in B are:
Experiment 5 (s) blank; (1) DOCA; (j) TH-DOCA; (m) DOCA 1 RU 28318; (n)
DOCA 1 RU 486; (h) TH-DOCA 1 RU 28318; (d) TH-DOCA 1Do the rapid effects of ALDO and DOC involve the RU 486. The results are presented as mean 6 SEM.
GABA/benzodiazepine receptor system?
The A-ring metabolites of DOC are known to bind
and activate the GABAa/benzodiazepine receptors in
Rats (N 5 6) were surgically fitted with cannula asvitro. It is possible that the actions of TH-DOC and TH-
described in the Methods section, and were maintainedALDO in evoking salt intake are occurring through a
on normal food and water, as well as daily access to 0.25nonclassic MR, since (1) the onset of the appetite occurs
mol/L NaCl. On the test day, the rats were treated withwith short latency, and (2) as shown in experiment 4,
either the GABA agonist flunitrazepam, TH-DOC (allthe pretreatment of the brain with RU 28318 is only
implants approximately 200 pg), or a blank cannula, andeffective in interfering with the action of ALDO, but not
their salt intake was recorded. In an effort to examineTH-ALDO, elicited salt intake. Thus, these TH steroids
the specificity of these effects, the GABA antagonistsmaybe acting on other receptor sites such as the GABAa
receptor. Ro15-4513 or Ro15-1788 were administered through the
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change in behavior supportive of this notion, but the use
of selective receptor antagonists used in these studies is
known to bind to cytosolic receptors for these steroids
though which upon after activation acts through the ge-
nome; however, the data using ASDNs against these
receptor mRNA also produced similar suppressions in
behavior, also supporting that these steroids were acting
through classic cytosolic receptor mechanisms. This is
not to say that the only actions of these adrenal steroids
are to act through the genome, as more recent evidence
also supports the idea that these steroids, as well as
others, may act membrane receptors and that the ring-
A–reduced forms of these compounds may have even
higher affinity and efficacy in eliciting rapid changes in
behavior though membrane receptors.
The results of this study also show that adrenal steroids
implanted into the amygdala can promote rapid and sig-
Fig. 6. An intake of 0.25 mol/L NaCl is increased by flunitrazepam
nificant increases in sodium intake in the rat. Most nota-and TH-DOC. Pretreatment with the GABA receptor antagonist Ro15-
bly, the increase in sodium intake occurred rapidly after4513 or Ro15-1788 inhibited flunitrazepam and TH-DOC saline intake.
Symbols are: (h) blank; (j) flunitrazepam; (n) TH-DOCA; (m) ROl5- application of the steroids, and the effects were not long
4513 1 flunitrazepam; (s) ROl5-4513 1 TH-DOCA; (d) ROl5-1788 1
lasting. That is, the increases in sodium intake were seenTH-DOCA.
as early as 15 minutes after steroid implantation during
the animals’ daily two-hour access to saline. These effects
on sodium intake were short lasting in that maintenance
same cannula just prior to the administration of either of the steroid implants overnight produced no increase
flunitrazepam or TH-DOC. in saline intake when examined the following day; more-
The GABA agonist flunitrazepam was effective in over, they were independent of the ability of antisense
stimulating salt intake when applied to the amygdala. to the MR to block salt appetite stimulated by ALDO
Figure 6 shows the intake of 0.25 mol/L NaCl during the or DOCA. Together, the data suggest that the adrenal
two-hour salt appetite test when the animals received steroids can arouse sodium intake in the sodium replete
either flunitrazepam or blank implants. Note that the rat when given directly into the amygdala in a relatively
intake of salt aroused by flunitrazepam is similar in both site-specific manner.
the onset of drinking and the volume consumed, as was The efficacy of adrenal steroids in arousing sodium
appetite showed a structure-activity profile. That is,seen with implants of TH-DOC. Pretreatment with ei-
ALDO and DOCA, as well as their tetrahydro deriva-ther Ro15-4513 or Ro15-1788 completely blocked the
tives, were most effective in arousing sodium intake,salt intake normally induced by either flunitrazepam or
whereas CORT, TH-CORT, and 3 a DHP were marginalTH-DOC (Fig. 6). Application of either of two antago-
to ineffective in arousing sodium intake when tested.nists alone had no affect on salt intake.
Although both ALDO and DOCA are known from pre-
vious work to arouse reliably sodium intake in the rat
DISCUSSION [1, 2, 20, 26, 27], the data from this study differ in three
The present study demonstrates the importance of important aspects. First, the steroids used in this study
brain type I MRs in the amygdala for the arousal of were applied directly in the brain; in other studies,
adrenal steroid-induced sodium intake. Moreover, the ALDO and DOCA were given either subcutaneously
data also demonstrate that the sodium intake can also or intravenously. Second, the tetrahydro derivative of
be either slowly or rapidly aroused by application of ALDO and DOCA were equally as effective as the par-
certain adrenal steroids or their A-ring derivatives. The ent steroids themselves. Third, the effects observed fol-
method of administration of the steroids by daily subcu- lowing application to the amygdala were rapid and had
taneous injection, and the temporal nature between the no long-term effects. The increases in saline intake oc-
time at which the steroid treatments were begun and the curred soon after steroid application and were absent 24
passing hours prior to when the elicitation of the behav- hours later, whereas systemic administration of ALDO
ior was evident, suggest that the subcutaneous method or DOCA given to animals in our lab usually takes 24
of delivery of adrenal steroids is acting through the ac- to 48 hours before an increase in saline intake is seen,
tions on the genome. Not only is the temporal nature of and the increase in saline intake persists for a few days
after the steroid treatment is terminated. The data fur-the addition of the steroids prior to the onset of the
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ther suggest that the population of cells stimulated by behavior. The amygdala is one brain area in which popu-
lations of both of these receptors coexist. The importancethe steroids may be acting via nonclassic cytosolic steroid
receptors. The inability of the type I (MR) antagonist of intact cell bodies in the amygdala is necessary for the
normal expression of mineralocorticoid-induced salineRU 28318 to block the effects of TH-ALDO–induced
sodium intake, along with the rapid elicitation of intake intake when the steroids are given systemically and are
then thought to exert their actions through genomicsoon after steroid treatment, suggests that these local
and rapid effects of steroids and their metabolites in mechanisms. As demonstrated here, direct stimulation
of these same cells by application of adrenal hormonesthe amygdala may be acting at membrane, rather than
intracellular receptors. A-ring reduction of the steroids evokes a rapid arousal of sodium intake in the rat, which
because of the quick elicitation of behavior may be actingcan occur within the brain, and the enzymes, primarily
5 a and 3 b reductase, are present in the amygdala [5, 28]. through membrane receptors rather than cytosolic recep-
tors.The TH steroids are thought to act by binding to GABAa/
benzodiazepine receptor complexes to evoke changes in
chloride channels [29, 30]. It is possible then that the ACKNOWLEDGMENTS
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